Artax Biopharma, Inc. — Form D

Artax Biopharma, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-09. The offering totals $8.0M, of which $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Robert ArmstrongDirectorCambridge, MA
Casper BreumDirectorNESS ZIONA, L3
Andre HoekemaDirectorCambridge, MA
Raj ParekhDirectorWaltham, MA
Gino SantiniDirectorCambridge, MA
Damia TormoDirectorCambridge, MA
Alan WaltsDirectorCambridge, MA
Robert ArmstrongExecutive OfficerCambridge, MA
Maria NicholExecutive OfficerCambridge, MA
Damia W Tormo, Ph.D.DirectorCambridge, MA
Alan W WaltsDirectorCambridge, MA
Raj W ParekhDirectorCambridge, MA
Robert W Armstrong, Ph.D.DirectorCambridge, MA
Robert W Armstrong, Ph.D.Executive OfficerCambridge, MA
Joe W SuarezExecutive OfficerCambridge, MA
Andre W HoekemaDirectorCambridge, MA
Maria W NicholExecutive OfficerCambridge, MA
Casper W BreumDirectorCambridge, MA
Gino W SantiniDirectorCambridge, MA
Gino SantiniRelated PersonCambridge, MA
Damia TormoExecutive OfficerCambridge, MA
Casper BreumRelated PersonNESS ZIONA, L3
Alan WaltsRelated PersonCambridge, MA
Andre HoekemaRelated PersonCambridge, MA
Maria NicholRelated PersonCambridge, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2026-05-05D/A$19.0M$19.0M
2025-07-29D/A$11.0M$11.0M
2022-05-18D/A$25.8M$25.8M
2022-01-03D$23.2M$12.7M
2021-02-26D$3.0M$2.2M
2020-05-04D$2.0M$2.0M
2019-08-12D$3.5M$750K
2015-10-27D$10.0M$3.0M
2014-11-10D$2.0M$2.0M
2013-09-25D$2.0M$1.3M

More